BDBM17297 4-[({1-methyl-5-[(2-methyl-1H-1,3-benzodiazol-1-yl)methyl]-1H-1,3-benzodiazol-2-yl}methyl)amino]benzene-1-carboximidamide::BIBR1109

SMILES Cc1nc2ccccc2n1Cc1ccc2n(C)c(CNc3ccc(cc3)C(N)=N)nc2c1

InChI Key InChIKey=IRKPNOLLMNHSOU-UHFFFAOYSA-N

Data  8 KI

PDB links: 3 PDB IDs match this monomer.

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 17297   

TargetCoagulation factor X(Homo sapiens (Human))
Boehringer Ingelheim Pharma

LigandPNGBDBM17297(4-[({1-methyl-5-[(2-methyl-1H-1,3-benzodiazol-1-yl...)
Affinity DataKi:  40nM ΔG°:  -10.5kcal/molepH: 8.0 T: 2°CAssay Description:For determination of the inhibition constants (Ki), enzyme inhibition was studied at three different substrate concentrations and seven different con...More data for this Ligand-Target Pair
TargetSerine protease 1(Bos taurus (bovine))
Boehringer Ingelheim Pharma

LigandPNGBDBM17297(4-[({1-methyl-5-[(2-methyl-1H-1,3-benzodiazol-1-yl...)
Affinity DataKi:  67nM ΔG°:  -10.2kcal/molepH: 8.0 T: 2°CAssay Description:For determination of the inhibition constants (Ki), enzyme inhibition was studied at three different substrate concentrations and seven different con...More data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Boehringer Ingelheim Pharma

LigandPNGBDBM17297(4-[({1-methyl-5-[(2-methyl-1H-1,3-benzodiazol-1-yl...)
Affinity DataKi:  780nM ΔG°:  -8.66kcal/molepH: 8.0 T: 2°CAssay Description:For determination of the inhibition constants (Ki), enzyme inhibition was studied at three different substrate concentrations and seven different con...More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Boehringer Ingelheim Pharma

LigandPNGBDBM17297(4-[({1-methyl-5-[(2-methyl-1H-1,3-benzodiazol-1-yl...)
Affinity DataKi:  4.10E+3nM ΔG°:  -7.64kcal/molepH: 8.0 T: 2°CAssay Description:For determination of the inhibition constants (Ki), enzyme inhibition was studied at three different substrate concentrations and seven different con...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Boehringer Ingelheim Pharma

LigandPNGBDBM17297(4-[({1-methyl-5-[(2-methyl-1H-1,3-benzodiazol-1-yl...)
Affinity DataKi:  9.20E+3nM ΔG°:  -7.14kcal/molepH: 8.0 T: 2°CAssay Description:For determination of the inhibition constants (Ki), enzyme inhibition was studied at three different substrate concentrations and seven different con...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Boehringer Ingelheim Pharma

LigandPNGBDBM17297(4-[({1-methyl-5-[(2-methyl-1H-1,3-benzodiazol-1-yl...)
Affinity DataKi:  1.60E+4nM ΔG°:  -6.80kcal/molepH: 8.0 T: 2°CAssay Description:For determination of the inhibition constants (Ki), enzyme inhibition was studied at three different substrate concentrations and seven different con...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor VII(Homo sapiens (Human))
Boehringer Ingelheim Pharma

LigandPNGBDBM17297(4-[({1-methyl-5-[(2-methyl-1H-1,3-benzodiazol-1-yl...)
Affinity DataKi: >4.00E+4nM ΔG°: >-6.24kcal/molepH: 8.0 T: 2°CAssay Description:For determination of the inhibition constants (Ki), enzyme inhibition was studied at three different substrate concentrations and seven different con...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue-type plasminogen activator(Homo sapiens (Human))
Boehringer Ingelheim Pharma

LigandPNGBDBM17297(4-[({1-methyl-5-[(2-methyl-1H-1,3-benzodiazol-1-yl...)
Affinity DataKi: >5.00E+4nM ΔG°: >-6.10kcal/molepH: 8.0 T: 2°CAssay Description:For determination of the inhibition constants (Ki), enzyme inhibition was studied at three different substrate concentrations and seven different con...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed